Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07048652

Evaluating the Diagnostic Performance of (HRCT) in IPD Fibrosis in Suspected Cases

This will be a cross-sectional descriptive study aimed at evaluating the role of high-resolution computed tomography (HRCT) in diagnosing Idiopathic Pulmonary Fibrosis (IPF).

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

AYK Hospital

Lahore, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 18 years and above.
  • Patients clinically suspected of having IPF.
  • Patients referred for HRCT examination.
  • Patients who provide informed consent to participate in the study.

Exclusion criteria

  • Patients with a known diagnosis of other interstitial lung diseases.
  • Patients with comorbid conditions that could mimic IPF.
  • Patients who are pregnant.
  • Patients with incomplete medical records or imaging studies

Treatment and study plan

High-Resolution Computed Tomography

Diagnostic Test

High-resolution computed tomography (HRCT) plays a crucial role in diagnosing and managing Idiopathic Pulmonary Fibrosis (IPF). It helps identify the characteristic pattern of IPF, known as Usual Interstitial Pneumonia (UIP), and can sometimes obviate the need for lung biopsy.

Primary outcomes

  1. high-resolution computed tomography (HRCT)

    Time frame: 12 Months

    Idiopathic Pulmonary Fibrosis (IPF) high-resolution computed tomography (HRCT) scans are crucial for diagnosis and assessment of disease severity. HRCT findings typically show a reticular pattern with traction bronchiectasis and honeycombing, predominantly in the subpleural and basal regions of the lungs

Sponsors and collaborators

Lead sponsor

Superior University

Other

Registry information

Official study title

Evaluating the Diagnostic Performance of High-Resolution Computed Tomography (HRCT) in Detecting Idiopathic Pulmonary Fibrosis (IPF) in Suspected Cases

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Jul 2, 2025
Registry last updated
Jul 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.